List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Value Chain Analysis 19
Figure 5. North America Electrocardiograph Market, 2021-2031, $ mn 20
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of North America Electrocardiograph Market 25
Figure 8. Worldwide Prevalence of Cardiovascular Disorders, 1990-2019, million 28
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 29
Figure 11. Primary Restraints and Impact Factors of North America Electrocardiograph Market 31
Figure 12. Investment Opportunity Analysis 35
Figure 13. Porter’s Fiver Forces Analysis of North America Electrocardiograph Market 38
Figure 14. Breakdown of North America Electrocardiograph Market by Product Type, 2021-2031, % of Revenue 43
Figure 15. North America Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 43
Figure 16. North America Electrocardiograph Market by Product Type: Conventional Devices, 2021-2031, $ mn 44
Figure 17. North America Electrocardiograph Market by Conventional Devices: Resting ECG Devices, 2021-2031, $ mn 45
Figure 18. North America Electrocardiograph Market by Conventional Devices: Stress ECG Devices, 2021-2031, $ mn 46
Figure 19. North America Electrocardiograph Market by Product Type: Emerging Devices, 2021-2031, $ mn 47
Figure 20. North America Electrocardiograph Market by Emerging Devices: Implantable Loop Recorders, 2021-2031, $ mn 49
Figure 21. North America Electrocardiograph Market by Emerging Devices: Mobile Cardiac Telemetry, 2021-2031, $ mn 50
Figure 22. North America Electrocardiograph Market by Emerging Devices: Holter Monitors, 2021-2031, $ mn 51
Figure 23. North America Electrocardiograph Market by Emerging Devices: Cardiac Event Monitors, 2021-2031, $ mn 52
Figure 24. North America Electrocardiograph Market by Emerging Devices: Smart ECG Monitors, 2021-2031, $ mn 53
Figure 25. North America Electrocardiograph Market by Product Type: Software & Services, 2021-2031, $ mn 54
Figure 26. Breakdown of North America Electrocardiograph Market by Lead Type, 2021-2031, % of Sales Revenue 56
Figure 27. North America Addressable Market Cap in 2022-2031 by Lead Type, Value ($ mn) and Share (%) 56
Figure 28. North America Electrocardiograph Market by Lead Type: Single-Lead Type ECG Devices, 2021-2031, $ mn 57
Figure 29. North America Electrocardiograph Market by Lead Type: 3-Lead Type ECG Devices, 2021-2031, $ mn 58
Figure 30. North America Electrocardiograph Market by Lead Type: 5-Lead Type ECG Devices, 2021-2031, $ mn 59
Figure 31. North America Electrocardiograph Market by Lead Type: 6-Lead Type ECG Devices, 2021-2031, $ mn 60
Figure 32. North America Electrocardiograph Market by Lead Type: 12-Lead Type ECG Devices, 2021-2031, $ mn 61
Figure 33. North America Electrocardiograph Market by Lead Type: Other Lead Types, 2021-2031, $ mn 62
Figure 34. Breakdown of North America Electrocardiograph Market by Function, 2021-2031, % of Sales Revenue 64
Figure 35. North America Addressable Market Cap in 2022-2031 by Function, Value ($ mn) and Share (%) 64
Figure 36. North America Electrocardiograph Market by Function: Diagnostic ECG Systems, 2021-2031, $ mn 65
Figure 37. North America Electrocardiograph Market by Function: Monitoring ECG Systems, 2021-2031, $ mn 66
Figure 38. Breakdown of North America Electrocardiograph Market by Technology, 2021-2031, % of Revenue 68
Figure 39. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 68
Figure 40. North America Electrocardiograph Market by Technology: Portable ECG Systems, 2021-2031, $ mn 69
Figure 41. North America Electrocardiograph Market by Technology: Wireless ECG Systems, 2021-2031, $ mn 70
Figure 42. Breakdown of North America Electrocardiograph Market by End User, 2021-2031, % of Revenue 72
Figure 43. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 72
Figure 44. North America Electrocardiograph Market by End User: Hospitals and Clinics, 2021-2031, $ mn 73
Figure 45. North America Electrocardiograph Market by End User: Ambulatory Surgical Centers (ASCs), 2021-2031, $ mn 74
Figure 46. North America Electrocardiograph Market by End User: Home-based Users, 2021-2031, $ mn 75
Figure 47. North America Electrocardiograph Market by End User: Cardiac Centers, 2021-2031, $ mn 76
Figure 48. North America Electrocardiograph Market by End User: Other End Users, 2021-2031, $ mn 77
Figure 49. Breakdown of North America Electrocardiograph Market by Country, 2021 and 2031, % of Revenue 79
Figure 50. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 80
Figure 51. U.S. Electrocardiograph Market, 2021-2031, $ mn 82
Figure 52. Canada Electrocardiograph Market, 2021-2031, $ mn 84
Figure 53. Electrocardiograph Market in Mexico, 2021-2031, $ mn 86
Figure 54. Growth Stage of North America Electrocardiograph Industry over the Forecast Period 88
North America electrocardiograph (ECG) market is projected to grow by 5.5% annually in the forecast period and reach $ 4,246.6 million by 2031, driven by the rising incidences of cardiac disorders and lifestyle related diseases, constantly increasing incidences of casualties due to cardiovascular diseases (CVDs), the increase in geriatric population coupled with behavioral risk factors such as rise in alcohol consumption and smoking, technological advancement and innovations, and the increasing healthcare expenditure. Highlighted with 24 tables and 54 figures, this 113-page report “North America Electrocardiograph (ECG) Market 2021-2031 by Product Type (Conventional Devices, Emerging Devices, Software & Services), Lead Type (Single-lead, 3-lead, 5-lead, 6-lead, 12-lead), Function (Diagnostic, Monitoring), Technology (Portable, Wireless), End User (Hospitals and Clinics, ASCs, Home-based Users, Cardiac Centers), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America electrocardiograph (ECG) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America electrocardiograph (ECG) market in every aspect of the classification from perspectives of Product Type, Lead Type, Function, Technology, End User, and Country. Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Conventional Devices o Resting ECG Devices o Stress ECG Devices • Emerging Devices o Implantable Loop Recorders o Mobile Cardiac Telemetry o Holter Monitors o Cardiac Event Monitors o Smart ECG Monitors • Software & Services Based on Lead Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single-Lead Type ECG Devices • 3-Lead Type ECG Devices • 5-Lead Type ECG Devices • 6-Lead Type ECG Devices • 12-Lead Type ECG Devices • Other Lead Types By Function, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic ECG Systems • Monitoring ECG Systems By Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Portable ECG Systems • Wireless ECG Systems By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Clinics • Ambulatory Surgical Centers (ASCs) • Home-based Users • Cardiac Centers • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Lead Type and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories ACS Diagnostics Biotricity, Inc. BIOTRONIK SE & Co. KG Boston Scientific Corporation CardioComm Solutions, Inc. Cardioline SpA Edan Instruments, Inc. Fukuda Denshi Co., Ltd. General Electric Company Hill-Rom Holdings, Inc. iRhythm Technologies, Inc. Koninklijke Philips N.V. Medtronic plc Mindray Medical International Limited Nihon Kohden Corporation OSI Systems, Inc. Schiller AG Suzuken Co., Ltd. Zoll Medical Corporation (Asahi Kasei Corporation) (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More